It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.
The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2011, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 950+ delegates from 588 companies who participated in 2,550+ scheduled one-to-one meetings.
For information about the BioPharm America 2012 program and registration information, please register your email address for regular updates from EBD Group at update@ebdgroup.com.
Further details and to register
